Aspen Pharmacare 

$10.8
22
+$0.2+1.89% 今天

統計

當日最高
10.6
當日最低
10.6
52週最高
13.69
52週最低
8.45
成交量
24
平均成交量
325
市值
5.99B
市盈率
22.11
股息收益率
1.89%
股息
0.2

即將到來

股息

1.89%股息收益率
10年增長
N/A
5年增長率
N/A
3年增長率
4.9%
1年增長率
11.6%

收益

3Sep預期
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q4 2023
Q2 2024
0
0.18
0.37
0.55
預期每股收益
0.55146
實際每股收益
0.55146

人們還關注

此列表基於在 Stock Events 上關注 APNHY 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Pharmaceuticals: Generic
Health Technology
Manufacturing
Medicinal and Botanical Manufacturing
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.
Show more...
首席執行官
Stephen Saad
員工
8612
國家
US
ISIN
US04530Y1064

上市公司